Does AMBRISENTAN Cause Infusion site extravasation? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Infusion site extravasation have been filed in association with AMBRISENTAN (AMBRISENTAN). This represents 0.0% of all adverse event reports for AMBRISENTAN.
22
Reports of Infusion site extravasation with AMBRISENTAN
0.0%
of all AMBRISENTAN reports
0
Deaths
10
Hospitalizations
How Dangerous Is Infusion site extravasation From AMBRISENTAN?
Of the 22 reports, 10 (45.5%) required hospitalization.
Is Infusion site extravasation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMBRISENTAN. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does AMBRISENTAN Cause?
Dyspnoea (13,367)
Death (7,497)
Headache (7,325)
Pneumonia (4,693)
Dizziness (4,561)
Fatigue (4,436)
Diarrhoea (4,312)
Nausea (3,986)
Fluid retention (3,927)
Malaise (3,839)
What Other Drugs Cause Infusion site extravasation?
HUMAN IMMUNOGLOBULIN G (822)
INFLIXIMAB (435)
INFLIXIMAB-DYYB (328)
TREPROSTINIL (256)
VEDOLIZUMAB (199)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (185)
REMDESIVIR (144)
FERRIC CARBOXYMALTOSE (118)
RITUXIMAB (82)
NATALIZUMAB (70)
Which AMBRISENTAN Alternatives Have Lower Infusion site extravasation Risk?
AMBRISENTAN vs AMBROSIA ARTEMISIIFOLIA POLLEN
AMBRISENTAN vs AMBROXOL
AMBRISENTAN vs AMDINOCILLIN PIVOXIL
AMBRISENTAN vs AMG-510
AMBRISENTAN vs AMIFAMPRIDINE